Literature DB >> 12359614

Combined cataract extraction and Baerveldt glaucoma drainage implant: indications and outcomes.

Kara B Hoffman1, Robert M Feldman, Donald L Budenz, Steven J Gedde, Grace Abou Chacra, Joyce C Schiffman.   

Abstract

PURPOSE: To report the indications and outcomes of simultaneous cataract extraction (CE) and Baerveldt glaucoma drainage implant surgery.
DESIGN: Noncomparative, interventional, retrospective, consecutive case series. PARTICIPANTS: Thirty-three eyes of 33 patients. INTERVENTION: Combined phacoemulsification CE and Baerveldt glaucoma drainage implant (BGI) surgery at two tertiary care referral centers. MAIN OUTCOME MEASURES: Visual acuity, intraocular pressure (IOP), and complications.
RESULTS: The study included 33 eyes of 33 patients followed for an average of 15.4 months (range, 3.0-46.9). The most common indication for combined CE and Baerveldt glaucoma drainage implant surgery was a history of prior failed trabeculectomy. Postoperative visual acuity at last follow-up was > or =20/40 in 12 of 33 patients (36%). IOP was reduced from a mean (+/- standard deviation) of 21 +/- 7.3 mmHg preoperatively to 13.1 +/- 3.5 mmHg at last follow-up visit ( P < 0.001). The number of antiglaucoma medications was reduced from a mean (+/- standard deviation) of 2.3 +/- 1.0 preoperatively to 0.7 +/- 1.1 at last follow-up (P < 0.001). Three eyes met our criteria for failure, and cumulative survival of the glaucoma surgery at 18 months was 89%. Intraoperative complications were all related to the cataract surgery, whereas early and late postoperative complications were related both to the CE and BGI surgery.
CONCLUSIONS: Combined CE and Baerveldt glaucoma drainage implant placement seems to be a safe and effective surgical option and may be preferred in certain clinical situations.

Entities:  

Mesh:

Year:  2002        PMID: 12359614     DOI: 10.1016/s0161-6420(02)01185-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

Review 1.  Aqueous shunts for glaucoma.

Authors:  D S Minckler; S S Vedula; T J Li; M C Mathew; R S Ayyala; B A Francis
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 2.  Aqueous shunts for glaucoma.

Authors:  Victoria L Tseng; Anne L Coleman; Melinda Y Chang; Joseph Caprioli
Journal:  Cochrane Database Syst Rev       Date:  2017-07-28

3.  Implantation of a second glaucoma drainage device.

Authors:  Brian A Francis; Rodrigo A B Fernandes; Handan Akil; Vikas Chopra; Bruno Diniz; James Tan; Alex Huang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-02-07       Impact factor: 3.117

4.  Intermediate-term outcomes of combined phacoemulsification and Aurolab aqueous drainage implant in eyes with refractory glaucoma and coexistent cataract.

Authors:  Sharmila Rajendrababu; George Varghese Puthuran; Laxmi Ananya Alia; Mohammed Sithiq Uduman; Hiruni Kaushalya Wijesinghe
Journal:  Int Ophthalmol       Date:  2022-04-20       Impact factor: 2.029

5.  Commentary: Combined cataract extraction with a new nonvalved glaucoma drainage device in adult eyes with cataract and refractory glaucoma.

Authors:  Harsh Kumar
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

6.  Combined cataract extraction with a new nonvalved glaucoma drainage device in adult eyes with cataract and refractory glaucoma.

Authors:  Divya P Rao; Vanita Pathak-Ray
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

7.  Risk factors for tube shunt exposure: a matched case-control study.

Authors:  Michael S Koval; Fouad F El Sayyad; Nicholas P Bell; Alice Z Chuang; David A Lee; Stephen M Hypes; Davinder S Grover; Laura A Baker; Stephen M Huddleston; Donald L Budenz; Robert M Feldman
Journal:  J Ophthalmol       Date:  2013-07-21       Impact factor: 1.909

8.  Factors Associated with Outcomes of Combined Phacoemulsification and Ahmed Glaucoma Valve Implantation.

Authors:  Junki Kwon; Kyung Rim Sung
Journal:  Korean J Ophthalmol       Date:  2018-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.